There’s a new fight brewing between manufacturers of weight loss drugs and the compounding pharmacies that have been allowed to make copycat versions during shortages. Federal regulators shook up a ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
About 154 million non-elderly Americans rely on employer-sponsored coverage, and the 26th annual survey of more than 2,100 ...
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...
We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...
Goldberg revealed she was using one, too. RELATED: 18 celebrities who’ve opened up about taking Ozempic or weight-loss drugs Fans once again marveled at Clarkson when she appeared at the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback